Literature DB >> 16096829

Human gene therapy and imaging: cardiology.

Joseph C Wu1, Seppo Yla-Herttuala.   

Abstract

This review discusses the basics of cardiovascular gene therapy, the results of recent human clinical trials, and the rapid progress in imaging techniques in cardiology. Improved understanding of the molecular and genetic basis of coronary heart disease has made gene therapy a potential new alternative for the treatment of cardiovascular diseases. Experimental studies have established the proof-of-principle that gene transfer to the cardiovascular system can achieve therapeutic effects. First human clinical trials provided initial evidence of feasibility and safety of cardiovascular gene therapy. However, phase II/III clinical trials have so far been rather disappointing and one of the major problems in cardiovascular gene therapy has been the inability to verify gene expression in the target tissue. New imaging techniques could significantly contribute to the development of better gene therapeutic approaches. Although the exact choice of imaging modality will depend on the biological question asked, further improvement in image resolution and detection sensitivity will be needed for all modalities as we move from imaging of organs and tissues to imaging of cells and genes.

Entities:  

Mesh:

Year:  2005        PMID: 16096829     DOI: 10.1007/s00259-005-1897-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  48 in total

Review 1.  Molecular-genetic imaging: current and future perspectives.

Authors:  Ronald G Blasberg; Juri Gelovani Tjuvajev
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 2.  Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.

Authors:  Seppo Ylä-Herttuala; Johanna E Markkanen; Tuomas T Rissanen
Journal:  Trends Cardiovasc Med       Date:  2004-11       Impact factor: 6.677

3.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.

Authors:  D A Sipkins; D A Cheresh; M R Kazemi; L M Nevin; M D Bednarski; K C Li
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

4.  Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors.

Authors:  S S Yaghoubi; L Wu; Q Liang; T Toyokuni; J R Barrio; M Namavari; N Satyamurthy; M E Phelps; H R Herschman; S S Gambhir
Journal:  Gene Ther       Date:  2001-07       Impact factor: 5.250

5.  Optical imaging of cardiac reporter gene expression in living rats.

Authors:  Joseph C Wu; Masayuki Inubushi; Gobalakrishnan Sundaresan; Heinrich R Schelbert; Sanjiv S Gambhir
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

6.  The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.

Authors:  Timothy D Henry; Brian H Annex; George R McKendall; Michael A Azrin; John J Lopez; Frank J Giordano; P K Shah; James T Willerson; Raymond L Benza; Daniel S Berman; C Michael Gibson; Alex Bajamonde; Amy Chen Rundle; Jennifer Fine; Edward R McCluskey
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

7.  Positron-emission tomography reporter gene expression imaging in rat myocardium.

Authors:  Masayuki Inubushi; Joseph C Wu; Sanjiv S Gambhir; Gobalakrishnan Sundaresan; Nagichettiar Satyamurthy; Mohammad Namavari; Simon Yee; Jorge R Barrio; David Stout; Arion F Chatziioannou; Lily Wu; Heinrich R Schelbert
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

8.  Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction.

Authors:  David F Meoli; Mehran M Sadeghi; Svetlana Krassilnikova; Brian N Bourke; Frank J Giordano; Donald P Dione; Haili Su; D Scott Edwards; Shuang Liu; Thomas D Harris; Joseph A Madri; Barry L Zaret; Albert J Sinusas
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

9.  Efficient gene transfer into myocardium by direct injection of adenovirus vectors.

Authors:  R J Guzman; P Lemarchand; R G Crystal; S E Epstein; T Finkel
Journal:  Circ Res       Date:  1993-12       Impact factor: 17.367

10.  Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter.

Authors:  Wolfgang Boecker; Oliver Y Bernecker; Joseph C Wu; Xinsheng Zhu; Tomohiro Sawa; Luanda Grazette; Anthony Rosenzweig; Federica del Monte; Ulrich Schmidt; Roger J Hajjar
Journal:  Mol Imaging       Date:  2004-04       Impact factor: 4.488

View more
  5 in total

1.  Molecular imaging of RNA interference therapy targeting PHD2 for treatment of myocardial ischemia.

Authors:  Mei Huang; Joseph C Wu
Journal:  Methods Mol Biol       Date:  2011

2.  Novel minicircle vector for gene therapy in murine myocardial infarction.

Authors:  Mei Huang; ZhiYing Chen; Shijun Hu; Fangjun Jia; Zongjin Li; Grant Hoyt; Robert C Robbins; Mark A Kay; Joseph C Wu
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

3.  Positron emission tomography imaging of conditional gene activation in the heart.

Authors:  Gwendolen Y Chang; Feng Cao; Manickam Krishnan; Mei Huang; Zongjin Li; Xiaoyan Xie; Ahmad Y Sheikh; Grant Hoyt; Robert C Robbins; Tzung Hsiai; Michael D Schneider; Joseph C Wu
Journal:  J Mol Cell Cardiol       Date:  2007-03-24       Impact factor: 5.000

4.  Noninvasive imaging of hypoxia-inducible factor-1α gene therapy for myocardial ischemia.

Authors:  Ian Y Chen; Olivier Gheysens; Zongjin Li; Julia A Rasooly; Qian Wang; Ramasamy Paulmurugan; Jarrett Rosenberg; Martin Rodriguez-Porcel; Juergen K Willmann; David S Wang; Christopher H Contag; Robert C Robbins; Joseph C Wu; Sanjiv S Gambhir
Journal:  Hum Gene Ther Methods       Date:  2013-10       Impact factor: 2.396

Review 5.  Bioluminescence imaging: a shining future for cardiac regeneration.

Authors:  Santiago Roura; Carolina Gálvez-Montón; Antoni Bayes-Genis
Journal:  J Cell Mol Med       Date:  2013-02-12       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.